Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas

M. K. Dodson, L. C. Hartmann, William Arthur Cliby, K. A. DeLacey, Gary Keeney, S. R. Ritland, J. Q. Su, K. C. Podratz, Robert Brian Jenkins

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Loss of heterozygosity (LOH) studies were performed to investigate the genetic differences which separate low-grade (LG), high-grade (HG), and borderline epithelial ovarian carcinomas. Fresh tumor samples and blood were obtained from 58 patients (20 LG, 34 HG, and 4 borderline tumor specimens) undergoing surgery for ovarian carcinoma at Mayo Clinic. Tumors were graded using a modified Border's classification with invasive grades 1 and 2 considered LG, invasive grades 3 and 4 considered HG, and tumors with no evidence of stromal invasion classified as borderline. Polymorphism analysis was performed using 76 restriction fragment length polymorphisms and variable number of tandem repeats and 59 microsatellite markers representing all chromosome arms. Chromosome arms 6p, 17p, 17q, and 22q were found to be frequently lost in LG as well as HG tumors. Chromosome arms 13q and 15q were lost to a significantly greater extent in HG tumors compared to LG neoplasms (P = 0.003 and P = 0.08, respectively). Conversely, 3p loss was seen more frequently with LG tumors (P = 0.02). The majority of LG tumors (65%) did not show frequent LOH in the allelotype analysis. In fact, a subset of 7 (7 of 20) LG tumors accounted for 76% of the total allelic loss in the LG category. These tumors showed LOH almost identical to that of the HG neoplasms. Borderline tumors showed a low rate of allelic loss. There were no common events found between borderline and invasive tumors. Our data suggest that most HG tumors and a subset of LG tumors share genetic alterations at putative tumor suppressor genes detected by LOH studies. Chromosome 6 and 17 losses appear to be early events while 13q and 15q losses appear to be critical late events. However, a majority of LG tumors appear to develop as a consequence of an alternative mechanism(s) which is not detected by LOH studies. Possibilities include: (a) inactivation of tumor suppressor genes without LOH; (b) dominant negative gene(s) in which only one allele requires mutation; and (c) changes in dominant acting oncogenes. This unidentified phenomenon may be operative in borderline tumors as well.

Original languageEnglish (US)
Pages (from-to)4456-4460
Number of pages5
JournalCancer Research
Volume53
Issue number18
StatePublished - 1993

Fingerprint

Loss of Heterozygosity
Carcinoma
Neoplasms
Chromosomes
Tumor Suppressor Genes
Dominant Genes
Minisatellite Repeats
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 6

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. / Dodson, M. K.; Hartmann, L. C.; Cliby, William Arthur; DeLacey, K. A.; Keeney, Gary; Ritland, S. R.; Su, J. Q.; Podratz, K. C.; Jenkins, Robert Brian.

In: Cancer Research, Vol. 53, No. 18, 1993, p. 4456-4460.

Research output: Contribution to journalArticle

Dodson, MK, Hartmann, LC, Cliby, WA, DeLacey, KA, Keeney, G, Ritland, SR, Su, JQ, Podratz, KC & Jenkins, RB 1993, 'Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas', Cancer Research, vol. 53, no. 18, pp. 4456-4460.
Dodson, M. K. ; Hartmann, L. C. ; Cliby, William Arthur ; DeLacey, K. A. ; Keeney, Gary ; Ritland, S. R. ; Su, J. Q. ; Podratz, K. C. ; Jenkins, Robert Brian. / Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. In: Cancer Research. 1993 ; Vol. 53, No. 18. pp. 4456-4460.
@article{d160d45f74494179b26277ccd06aaef7,
title = "Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas",
abstract = "Loss of heterozygosity (LOH) studies were performed to investigate the genetic differences which separate low-grade (LG), high-grade (HG), and borderline epithelial ovarian carcinomas. Fresh tumor samples and blood were obtained from 58 patients (20 LG, 34 HG, and 4 borderline tumor specimens) undergoing surgery for ovarian carcinoma at Mayo Clinic. Tumors were graded using a modified Border's classification with invasive grades 1 and 2 considered LG, invasive grades 3 and 4 considered HG, and tumors with no evidence of stromal invasion classified as borderline. Polymorphism analysis was performed using 76 restriction fragment length polymorphisms and variable number of tandem repeats and 59 microsatellite markers representing all chromosome arms. Chromosome arms 6p, 17p, 17q, and 22q were found to be frequently lost in LG as well as HG tumors. Chromosome arms 13q and 15q were lost to a significantly greater extent in HG tumors compared to LG neoplasms (P = 0.003 and P = 0.08, respectively). Conversely, 3p loss was seen more frequently with LG tumors (P = 0.02). The majority of LG tumors (65{\%}) did not show frequent LOH in the allelotype analysis. In fact, a subset of 7 (7 of 20) LG tumors accounted for 76{\%} of the total allelic loss in the LG category. These tumors showed LOH almost identical to that of the HG neoplasms. Borderline tumors showed a low rate of allelic loss. There were no common events found between borderline and invasive tumors. Our data suggest that most HG tumors and a subset of LG tumors share genetic alterations at putative tumor suppressor genes detected by LOH studies. Chromosome 6 and 17 losses appear to be early events while 13q and 15q losses appear to be critical late events. However, a majority of LG tumors appear to develop as a consequence of an alternative mechanism(s) which is not detected by LOH studies. Possibilities include: (a) inactivation of tumor suppressor genes without LOH; (b) dominant negative gene(s) in which only one allele requires mutation; and (c) changes in dominant acting oncogenes. This unidentified phenomenon may be operative in borderline tumors as well.",
author = "Dodson, {M. K.} and Hartmann, {L. C.} and Cliby, {William Arthur} and DeLacey, {K. A.} and Gary Keeney and Ritland, {S. R.} and Su, {J. Q.} and Podratz, {K. C.} and Jenkins, {Robert Brian}",
year = "1993",
language = "English (US)",
volume = "53",
pages = "4456--4460",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas

AU - Dodson, M. K.

AU - Hartmann, L. C.

AU - Cliby, William Arthur

AU - DeLacey, K. A.

AU - Keeney, Gary

AU - Ritland, S. R.

AU - Su, J. Q.

AU - Podratz, K. C.

AU - Jenkins, Robert Brian

PY - 1993

Y1 - 1993

N2 - Loss of heterozygosity (LOH) studies were performed to investigate the genetic differences which separate low-grade (LG), high-grade (HG), and borderline epithelial ovarian carcinomas. Fresh tumor samples and blood were obtained from 58 patients (20 LG, 34 HG, and 4 borderline tumor specimens) undergoing surgery for ovarian carcinoma at Mayo Clinic. Tumors were graded using a modified Border's classification with invasive grades 1 and 2 considered LG, invasive grades 3 and 4 considered HG, and tumors with no evidence of stromal invasion classified as borderline. Polymorphism analysis was performed using 76 restriction fragment length polymorphisms and variable number of tandem repeats and 59 microsatellite markers representing all chromosome arms. Chromosome arms 6p, 17p, 17q, and 22q were found to be frequently lost in LG as well as HG tumors. Chromosome arms 13q and 15q were lost to a significantly greater extent in HG tumors compared to LG neoplasms (P = 0.003 and P = 0.08, respectively). Conversely, 3p loss was seen more frequently with LG tumors (P = 0.02). The majority of LG tumors (65%) did not show frequent LOH in the allelotype analysis. In fact, a subset of 7 (7 of 20) LG tumors accounted for 76% of the total allelic loss in the LG category. These tumors showed LOH almost identical to that of the HG neoplasms. Borderline tumors showed a low rate of allelic loss. There were no common events found between borderline and invasive tumors. Our data suggest that most HG tumors and a subset of LG tumors share genetic alterations at putative tumor suppressor genes detected by LOH studies. Chromosome 6 and 17 losses appear to be early events while 13q and 15q losses appear to be critical late events. However, a majority of LG tumors appear to develop as a consequence of an alternative mechanism(s) which is not detected by LOH studies. Possibilities include: (a) inactivation of tumor suppressor genes without LOH; (b) dominant negative gene(s) in which only one allele requires mutation; and (c) changes in dominant acting oncogenes. This unidentified phenomenon may be operative in borderline tumors as well.

AB - Loss of heterozygosity (LOH) studies were performed to investigate the genetic differences which separate low-grade (LG), high-grade (HG), and borderline epithelial ovarian carcinomas. Fresh tumor samples and blood were obtained from 58 patients (20 LG, 34 HG, and 4 borderline tumor specimens) undergoing surgery for ovarian carcinoma at Mayo Clinic. Tumors were graded using a modified Border's classification with invasive grades 1 and 2 considered LG, invasive grades 3 and 4 considered HG, and tumors with no evidence of stromal invasion classified as borderline. Polymorphism analysis was performed using 76 restriction fragment length polymorphisms and variable number of tandem repeats and 59 microsatellite markers representing all chromosome arms. Chromosome arms 6p, 17p, 17q, and 22q were found to be frequently lost in LG as well as HG tumors. Chromosome arms 13q and 15q were lost to a significantly greater extent in HG tumors compared to LG neoplasms (P = 0.003 and P = 0.08, respectively). Conversely, 3p loss was seen more frequently with LG tumors (P = 0.02). The majority of LG tumors (65%) did not show frequent LOH in the allelotype analysis. In fact, a subset of 7 (7 of 20) LG tumors accounted for 76% of the total allelic loss in the LG category. These tumors showed LOH almost identical to that of the HG neoplasms. Borderline tumors showed a low rate of allelic loss. There were no common events found between borderline and invasive tumors. Our data suggest that most HG tumors and a subset of LG tumors share genetic alterations at putative tumor suppressor genes detected by LOH studies. Chromosome 6 and 17 losses appear to be early events while 13q and 15q losses appear to be critical late events. However, a majority of LG tumors appear to develop as a consequence of an alternative mechanism(s) which is not detected by LOH studies. Possibilities include: (a) inactivation of tumor suppressor genes without LOH; (b) dominant negative gene(s) in which only one allele requires mutation; and (c) changes in dominant acting oncogenes. This unidentified phenomenon may be operative in borderline tumors as well.

UR - http://www.scopus.com/inward/record.url?scp=0027420588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027420588&partnerID=8YFLogxK

M3 - Article

C2 - 8402612

AN - SCOPUS:0027420588

VL - 53

SP - 4456

EP - 4460

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -